Figure 2From: Blood expression levels of chemokine receptor CCR3 and chemokine CCL11 in age-related macular degeneration: a case–control study Percentage of CD9+ cells expressing CCR3 in young controls (< 70 years), aged controls (>70 years) and patients with neovascular AMD. Each dot represents one patient. The lines denote medians and interquartile ranges (IQR). No significant difference was found between the groups.Back to article page